Status:

COMPLETED

Safety and Effectiveness Study of Actinic Keratosis Treatment Following Cryosurgery

Lead Sponsor:

Graceway Pharmaceuticals, LLC

Conditions:

Actinic Keratosis

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

The objective of this study is to evaluate the efficacy and safety of imiquimod cream versus placebo cream when used after cryosurgery in the treatment of actinic keratoses (AKs).

Detailed Description

In this multicenter, randomized, double-blind, placebo-controlled study, the efficacy and safety of imiquimod 3.75% cream following cryosurgery to treat clinically typical visible or palpable AK lesio...

Eligibility Criteria

Inclusion

  • In good general health
  • Negative urine pregnancy test (for women of child-bearing potential) and agree to use an approved method of birth control while enrolled in the study.
  • Prior to cryosurgery, have ≥ 10 clinically typical (visible or palpable) AKs in an area that exceeds 25 cm2 on the face.
  • Must have had cryosurgery on 5 to 14 AKs on the face after giving informed consent and prior to receiving study medication. Lesions previously treated with cryosurgery must be healed sufficiently prior to randomization to study cream.
  • Following cryosurgery, have ≥ 5 clinically typical (visible or palpable) AKs in an area that exceeds 25 cm2 on the face that are suitable for treatment with the study cream.

Exclusion

  • Women who are pregnant, lactating, or planning to become pregnant during the study
  • Had a medical event within 90 days of the visit (e.g., stroke, heart attack, etc.).
  • Have any skin condition in the treatment area that may be made worse by treatment with imiquimod (e.g., rosacea, psoriasis, atopic dermatitis, eczema).
  • Have received specific treatments/medications in the treatment area within the designated time period prior to study treatment initiation

Key Trial Info

Start Date :

May 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

February 1 2010

Estimated Enrollment :

247 Patients enrolled

Trial Details

Trial ID

NCT00894647

Start Date

May 1 2009

End Date

February 1 2010

Last Update

August 31 2010

Active Locations (18)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 5 (18 locations)

1

Dermatology Research Associates

Los Angeles, California, United States, 90045

2

Therapeutics Clinical Research

San Diego, California, United States, 92123

3

Spencer Dermatology & Skin Surgery Center

Saint Petersberg, Florida, United States, 33705

4

Palm Beach Dermatology

West Palm Beach, Florida, United States, 33401